8:41 28/05/2015 Arena Pharmaceuticals, Inc. Price Target Update
Arena Pharmaceuticals, Inc. Price Target Update
News Watch International - 14 hours ago
Arena Pharmaceuticals, Inc. shares have received a Mean Price Target of $7.08. According to the rating issued from 6 Wall Street Analysts, the High Price Target is seen at $11 while the Lower end of the Price Target is seen at $4.

20:41 26/05/2015 Stock in Motion: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Stock in Motion: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Vanguard Tribune - May 26, 2015
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares opened the most recent trading session at 4.18 and at the time of writing the last Bid was at 4.13.

14:52 26/05/2015 Arena Pharmaceuticals: Hopes For Long-Term Value From Belviq Get A Lift ...
Arena Pharmaceuticals: Hopes For Long-Term Value From Belviq Get A Lift ...
Seeking Alpha - May 26, 2015
Sales of weight loss drug Belviq by Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have been disappointing. However, there is a significant and yet untapped market of obese patients.

13:00 26/05/2015 Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare ...
Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare ...
PR Newswire (press release) - May 26, 2015
SAN DIEGO, May 26, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, ...

19:22 22/05/2015 Arena: Belviq Sales Take Big Step Back - Advertising Needed
Arena: Belviq Sales Take Big Step Back - Advertising Needed
Seeking Alpha - May 22, 2015
Arena (NASDAQ:ARNA) investors have yet another frustrating week in terms of Belviq sales to consider over the long holiday weekend.

18:00 20/05/2015 Why These Three Stocks Active Today? Kohl's Corp. (NYSE:KSS), Arena ...
Why These Three Stocks Active Today? Kohl's Corp. (NYSE:KSS), Arena ...
wsnewspublishers - May 20, 2015
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors.

14:18 20/05/2015 Arena Pharmaceuticals Inc (NASDAQ:ARNA) in Focus
Arena Pharmaceuticals Inc (NASDAQ:ARNA) in Focus
Street Report - May 20, 2015
[PRNewswire] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) provided a corporate update and reported financial results for the first quarter ended March 31, 2015.
Arena: Belviq Sales Flattening Out - Is It Sector Saturation? (ARNA) - Seeking Alpha

14:15 18/05/2015 Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena ...
Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena ...
MarketWatch - May 18, 2015
Although Arena Pharmaceuticals Inc.'s stock has lost 8.41% in the last one month, it has advanced 0.24% in the previous three trading sessions and 22.48% on YTD basis.

20:41 12/05/2015 Needham Remains Neutral on Arena Pharmaceuticals, Inc. Following 1Q:15 ...
Needham Remains Neutral on Arena Pharmaceuticals, Inc. Following 1Q:15 ...
Smarter Analyst - May 12, 2015
Needham's healthcare analyst Alan Carr weighed in today with an update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), after the company reported first-quarter financial results and held a conference call last night to provide a corporate update.
Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for ... - MarketWatch
Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected - Zacks.com

20:11 07/05/2015 Will Arena Pharmaceuticals (ARNA) Surprise this Earnings?
Will Arena Pharmaceuticals (ARNA) Surprise this Earnings?
Zacks.com - May 7, 2015
Arena Pharmaceuticals, Inc. (ARNA - Analyst Report) is expected to report first-quarter 2015 results on May 11. Arena Pharma's performance has been mostly disappointing in 2014 with the company missing earnings expectations in three of the last four ...
Will Arena Pharmaceuticals (ARNA) Surprise this Earnings? - Analyst Blog - Nasdaq